Global and China Pharmaceutical CDMO Services Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Pharmaceutical CDMO Services industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Lonza

    • WuXi AppTec Group

    • Eurofins CDMO

    • Recipharm AB

    • FAMAR Health Care Services

    • Aenova

    • Patheon

    • Piramal Pharma Solutions

    • Fareva

    • AMRI

    • Catalent

    • Siegfried

    • Boehringer Ingelheim

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Active Pharmaceutical Ingredient (API) Manufacturing

    • Finished Dosage Formulation (FDF) Development & Manufacturing

    • Secondary Packaging

    Application:

    • Pre-clinical

    • Phase I

    • Phase II

    • Phase III

    • Phase IV

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Pharmaceutical CDMO Services Industry Overview

      • 1.1.1 Pharmaceutical CDMO Services Market Scope and Market Segments

      • 1.1.2 Pharmaceutical CDMO Services Industry Characteristics

      • 1.1.3 Global and China Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Pharmaceutical CDMO Services Production Value and Growth Rate (2017-2028)

    • 1.2 Global Pharmaceutical CDMO Services Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Active Pharmaceutical Ingredient (API) Manufacturing

      • 1.2.2 Finished Dosage Formulation (FDF) Development & Manufacturing

      • 1.2.3 Secondary Packaging

    • 1.3 Global Pharmaceutical CDMO Services Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Pre-clinical

      • 1.3.2 Phase I

      • 1.3.3 Phase II

      • 1.3.4 Phase III

      • 1.3.5 Phase IV

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Pharmaceutical CDMO Services Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Pharmaceutical CDMO Services Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Pharmaceutical CDMO Services Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Pharmaceutical CDMO Services Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Pharmaceutical CDMO Services Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Pharmaceutical CDMO Services Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Pharmaceutical CDMO Services Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Pharmaceutical CDMO Services Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Pharmaceutical CDMO Services Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Pharmaceutical CDMO Services Industry Porter's Five Forces Model Analysis

      • 2.2.3 Pharmaceutical CDMO Services Industry PEST Analysis

    • 2.3 Pharmaceutical CDMO Services Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Pharmaceutical CDMO Services Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Pharmaceutical CDMO Services Industry

    Chapter 3 Global and China Pharmaceutical CDMO Services Market, by Manufacturer

    • 3.1 Global and China Pharmaceutical CDMO Services Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Pharmaceutical CDMO Services Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Pharmaceutical CDMO Services Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Pharmaceutical CDMO Services Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Pharmaceutical CDMO Services Market Top 3 Players

    Chapter 4 Global and China Pharmaceutical CDMO Services Market, by Type (2017-2028)

    • 4.1 Pharmaceutical CDMO Services Market Trend, by Type

    • 4.2 Global Pharmaceutical CDMO Services Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Pharmaceutical CDMO Services Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Pharmaceutical CDMO Services Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Pharmaceutical CDMO Services Price Trend, by Type (2017-2028)

    • 4.3 China Pharmaceutical CDMO Services Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Pharmaceutical CDMO Services Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Pharmaceutical CDMO Services Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Pharmaceutical CDMO Services Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Pharmaceutical CDMO Services Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Pharmaceutical CDMO Services Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Pharmaceutical CDMO Services Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Pharmaceutical CDMO Services Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Pharmaceutical CDMO Services Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Pharmaceutical CDMO Services Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Pharmaceutical CDMO Services Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Pharmaceutical CDMO Services Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Pharmaceutical CDMO Services Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Pharmaceutical CDMO Services Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Pharmaceutical CDMO Services Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Pharmaceutical CDMO Services Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Pharmaceutical CDMO Services Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Pharmaceutical CDMO Services Market Analysis

    • 7.1 North America Pharmaceutical CDMO Services Market, by Type

    • 7.2 North America Pharmaceutical CDMO Services Market, by Application

    • 7.3 North America Pharmaceutical CDMO Services Market Analysis and Forecast, by Country

      • 7.3.1 United States Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Pharmaceutical CDMO Services Market Analysis

    • 8.1 Europe Pharmaceutical CDMO Services Market, by Type

    • 8.2 Europe Pharmaceutical CDMO Services Market, by Application

    • 8.3 Europe Pharmaceutical CDMO Services Market Analysis and Forecast, by Country

      • 8.3.1 Germany Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Pharmaceutical CDMO Services Market Analysis

    • 9.1 APAC Pharmaceutical CDMO Services Market, by Type

    • 9.2 APAC Pharmaceutical CDMO Services Market, by Application

    • 9.3 APAC Pharmaceutical CDMO Services Market Analysis and Forecast, by Country

      • 9.3.1 China Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Pharmaceutical CDMO Services Market Analysis

    • 10.1 Latin America, Middle East and Africa Pharmaceutical CDMO Services Market, by Type

    • 10.2 Latin America, Middle East and Africa Pharmaceutical CDMO Services Market, by Application

    • 10.3 Latin America, Middle East and Africa Pharmaceutical CDMO Services Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Pharmaceutical CDMO Services Company Profiles

      • 11.1 Lonza

        • 11.1.1 Lonza Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Lonza Pharmaceutical CDMO Services Product Profiles, Application and Specification

        • 11.1.3 Lonza Pharmaceutical CDMO Services Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 WuXi AppTec Group

        • 11.2.1 WuXi AppTec Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 WuXi AppTec Group Pharmaceutical CDMO Services Product Profiles, Application and Specification

        • 11.2.3 WuXi AppTec Group Pharmaceutical CDMO Services Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Eurofins CDMO

        • 11.3.1 Eurofins CDMO Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Eurofins CDMO Pharmaceutical CDMO Services Product Profiles, Application and Specification

        • 11.3.3 Eurofins CDMO Pharmaceutical CDMO Services Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Recipharm AB

        • 11.4.1 Recipharm AB Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Recipharm AB Pharmaceutical CDMO Services Product Profiles, Application and Specification

        • 11.4.3 Recipharm AB Pharmaceutical CDMO Services Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 FAMAR Health Care Services

        • 11.5.1 FAMAR Health Care Services Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 FAMAR Health Care Services Pharmaceutical CDMO Services Product Profiles, Application and Specification

        • 11.5.3 FAMAR Health Care Services Pharmaceutical CDMO Services Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Aenova

        • 11.6.1 Aenova Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Aenova Pharmaceutical CDMO Services Product Profiles, Application and Specification

        • 11.6.3 Aenova Pharmaceutical CDMO Services Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Patheon

        • 11.7.1 Patheon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Patheon Pharmaceutical CDMO Services Product Profiles, Application and Specification

        • 11.7.3 Patheon Pharmaceutical CDMO Services Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Piramal Pharma Solutions

        • 11.8.1 Piramal Pharma Solutions Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Piramal Pharma Solutions Pharmaceutical CDMO Services Product Profiles, Application and Specification

        • 11.8.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Fareva

        • 11.9.1 Fareva Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Fareva Pharmaceutical CDMO Services Product Profiles, Application and Specification

        • 11.9.3 Fareva Pharmaceutical CDMO Services Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 AMRI

        • 11.10.1 AMRI Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 AMRI Pharmaceutical CDMO Services Product Profiles, Application and Specification

        • 11.10.3 AMRI Pharmaceutical CDMO Services Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Catalent

        • 11.11.1 Catalent Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Catalent Pharmaceutical CDMO Services Product Profiles, Application and Specification

        • 11.11.3 Catalent Pharmaceutical CDMO Services Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Siegfried

        • 11.12.1 Siegfried Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Siegfried Pharmaceutical CDMO Services Product Profiles, Application and Specification

        • 11.12.3 Siegfried Pharmaceutical CDMO Services Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Boehringer Ingelheim

        • 11.13.1 Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Boehringer Ingelheim Pharmaceutical CDMO Services Product Profiles, Application and Specification

        • 11.13.3 Boehringer Ingelheim Pharmaceutical CDMO Services Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Pharmaceutical CDMO Services Industry Investment Prospect and Risk Assessment

    • 12.1 Pharmaceutical CDMO Services Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Pharmaceutical CDMO Services Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

    • Figure China Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

    • Figure Global Pharmaceutical CDMO Services Production Value and Growth Rate (2017-2028)

    • Figure China Pharmaceutical CDMO Services Production Value and Growth Rate (2017-2028)

    • Figure Global Pharmaceutical CDMO Services Market Size and Growth Rate of Active Pharmaceutical Ingredient (API) Manufacturing (2017-2028)

    • Figure Global Pharmaceutical CDMO Services Market Size and Growth Rate of Finished Dosage Formulation (FDF) Development & Manufacturing (2017-2028)

    • Figure Global Pharmaceutical CDMO Services Market Size and Growth Rate of Secondary Packaging (2017-2028)

    • Figure Global Pharmaceutical CDMO Services Market Size and Growth Rate of Pre-clinical (2017-2028)

    • Figure Global Pharmaceutical CDMO Services Market Size and Growth Rate of Phase I (2017-2028)

    • Figure Global Pharmaceutical CDMO Services Market Size and Growth Rate of Phase II (2017-2028)

    • Figure Global Pharmaceutical CDMO Services Market Size and Growth Rate of Phase III (2017-2028)

    • Figure Global Pharmaceutical CDMO Services Market Size and Growth Rate of Phase IV (2017-2028)

    • Figure North America Pharmaceutical CDMO Services Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Pharmaceutical CDMO Services Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Pharmaceutical CDMO Services Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Pharmaceutical CDMO Services Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Pharmaceutical CDMO Services Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Pharmaceutical CDMO Services Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Pharmaceutical CDMO Services Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Pharmaceutical CDMO Services Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Pharmaceutical CDMO Services Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Pharmaceutical CDMO Services Market Share, by Manufacturer in 2021

    • Figure Global and China Pharmaceutical CDMO Services Market Share, by Manufacturer in 2022

    • Table Global Pharmaceutical CDMO Services Sales Volume, by Type (2017-2028)

    • Table Global Pharmaceutical CDMO Services Sales Volume Share, by Type (2017-2028)

    • Figure Global Pharmaceutical CDMO Services Sales Volume Share, by Type (2017-2028)

    • Table Global Pharmaceutical CDMO Services Sales Value, by Type (2017-2028)

    • Table Global Pharmaceutical CDMO Services Sales Value Share, by Type (2017-2028)

    • Figure Global Pharmaceutical CDMO Services Price Trend, by Type (2017-2028)

    • Table China Pharmaceutical CDMO Services Sales Volume, by Type (2017-2028)

    • Table China Pharmaceutical CDMO Services Sales Volume Share, by Type (2017-2028)

    • Figure China Pharmaceutical CDMO Services Sales Volume Share, by Type (2017-2028)

    • Table China Pharmaceutical CDMO Services Sales Value, by Type (2017-2028)

    • Table China Pharmaceutical CDMO Services Sales Value Share, by Type (2017-2028)

    • Figure China Pharmaceutical CDMO Services Price Trend, by Type (2017-2028)

    • Table Global Pharmaceutical CDMO Services Sales Volume, by Application (2017-2028)

    • Table Global Pharmaceutical CDMO Services Sales Volume Share, by Application (2017-2028)

    • Figure Global Pharmaceutical CDMO Services Sales Volume Share, by Application (2017-2028)

    • Table Global Pharmaceutical CDMO Services Sales Value, by Application (2017-2028)

    • Table Global Pharmaceutical CDMO Services Sales Value Share, by Application (2017-2028)

    • Figure Global Pharmaceutical CDMO Services Sales Value Share, by Application (2017-2028)

    • Table China Pharmaceutical CDMO Services Sales Volume, by Application (2017-2028)

    • Table China Pharmaceutical CDMO Services Sales Volume Share, by Application (2017-2028)

    • Figure China Pharmaceutical CDMO Services Sales Volume Share, by Application (2017-2028)

    • Table China Pharmaceutical CDMO Services Sales Value, by Application (2017-2028)

    • Table China Pharmaceutical CDMO Services Sales Value Share, by Application (2017-2028)

    • Figure China Pharmaceutical CDMO Services Sales Value Share, by Application (2017-2028)

    • Figure China Pharmaceutical CDMO Services Production, Import, Consumption and Export (2017-2022)

    • Figure North America Pharmaceutical CDMO Services Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Pharmaceutical CDMO Services Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Pharmaceutical CDMO Services Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Pharmaceutical CDMO Services Production, Import, Consumption and Export (2017-2022)

    • Table North America Pharmaceutical CDMO Services Sales Volume, by Type (2017-2028)

    • Table North America Pharmaceutical CDMO Services Sales Volume Share, by Type (2017-2028)

    • Figure North America Pharmaceutical CDMO Services Sales Volume Share, by Type (2017-2028)

    • Table North America Pharmaceutical CDMO Services Sales Volume, by Application (2017-2028)

    • Table North America Pharmaceutical CDMO Services Sales Volume Share, by Application (2017-2028)

    • Figure North America Pharmaceutical CDMO Services Sales Volume Share, by Application (2017-2028)

    • Figure United States Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

    • Figure United States Pharmaceutical CDMO Services Sales Value and Growth Rate (2017-2028)

    • Figure Canada Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Pharmaceutical CDMO Services Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Pharmaceutical CDMO Services Sales Value and Growth Rate (2017-2028)

    • Table Europe Pharmaceutical CDMO Services Sales Volume, by Type (2017-2028)

    • Table Europe Pharmaceutical CDMO Services Sales Volume Share, by Type (2017-2028)

    • Figure Europe Pharmaceutical CDMO Services Sales Volume Share, by Type (2017-2028)

    • Table Europe Pharmaceutical CDMO Services Sales Volume, by Application (2017-2028)

    • Table Europe Pharmaceutical CDMO Services Sales Volume Share, by Application (2017-2028)

    • Figure Europe Pharmaceutical CDMO Services Sales Volume Share, by Application (2017-2028)

    • Figure Germany Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Pharmaceutical CDMO Services Sales Value and Growth Rate (2017-2028)

    • Figure UK Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

    • Figure UK Pharmaceutical CDMO Services Sales Value and Growth Rate (2017-2028)

    • Figure France Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

    • Figure France Pharmaceutical CDMO Services Sales Value and Growth Rate (2017-2028)

    • Figure Italy Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Pharmaceutical CDMO Services Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Pharmaceutical CDMO Services Sales Value and Growth Rate (2017-2028)

    • Figure Spain Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Pharmaceutical CDMO Services Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Pharmaceutical CDMO Services Sales Value and Growth Rate (2017-2028)

    • Figure Poland Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Pharmaceutical CDMO Services Sales Value and Growth Rate (2017-2028)

    • Figure Russia Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Pharmaceutical CDMO Services Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Pharmaceutical CDMO Services Sales Value and Growth Rate (2017-2028)

    • Table APAC Pharmaceutical CDMO Services Sales Volume, by Type (2017-2028)

    • Table APAC Pharmaceutical CDMO Services Sales Volume Share, by Type (2017-2028)

    • Figure APAC Pharmaceutical CDMO Services Sales Volume Share, by Type (2017-2028)

    • Table APAC Pharmaceutical CDMO Services Sales Volume, by Application (2017-2028)

    • Table APAC Pharmaceutical CDMO Services Sales Volume Share, by Application (2017-2028)

    • Figure APAC Pharmaceutical CDMO Services Sales Volume Share, by Application (2017-2028)

    • Figure China Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

    • Figure China Pharmaceutical CDMO Services Sales Value and Growth Rate (2017-2028)

    • Figure Japan Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Pharmaceutical CDMO Services Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Pharmaceutical CDMO Services Sales Value and Growth Rate (2017-2028)

    • Figure India Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

    • Figure India Pharmaceutical CDMO Services Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Pharmaceutical CDMO Services Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Pharmaceutical CDMO Services Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Pharmaceutical CDMO Services Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Pharmaceutical CDMO Services Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Pharmaceutical CDMO Services Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Pharmaceutical CDMO Services Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Pharmaceutical CDMO Services Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Pharmaceutical CDMO Services Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Pharmaceutical CDMO Services Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Pharmaceutical CDMO Services Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Pharmaceutical CDMO Services Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Pharmaceutical CDMO Services Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Pharmaceutical CDMO Services Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Pharmaceutical CDMO Services Sales Value and Growth Rate (2017-2028)

    • Table Lonza Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Lonza Product Profiles, Application and Specification

    • Table Lonza Pharmaceutical CDMO Services Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table WuXi AppTec Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table WuXi AppTec Group Product Profiles, Application and Specification

    • Table WuXi AppTec Group Pharmaceutical CDMO Services Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eurofins CDMO Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eurofins CDMO Product Profiles, Application and Specification

    • Table Eurofins CDMO Pharmaceutical CDMO Services Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Recipharm AB Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Recipharm AB Product Profiles, Application and Specification

    • Table Recipharm AB Pharmaceutical CDMO Services Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table FAMAR Health Care Services Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table FAMAR Health Care Services Product Profiles, Application and Specification

    • Table FAMAR Health Care Services Pharmaceutical CDMO Services Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Aenova Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Aenova Product Profiles, Application and Specification

    • Table Aenova Pharmaceutical CDMO Services Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Patheon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Patheon Product Profiles, Application and Specification

    • Table Patheon Pharmaceutical CDMO Services Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Piramal Pharma Solutions Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Piramal Pharma Solutions Product Profiles, Application and Specification

    • Table Piramal Pharma Solutions Pharmaceutical CDMO Services Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Fareva Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Fareva Product Profiles, Application and Specification

    • Table Fareva Pharmaceutical CDMO Services Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AMRI Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AMRI Product Profiles, Application and Specification

    • Table AMRI Pharmaceutical CDMO Services Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Catalent Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Catalent Product Profiles, Application and Specification

    • Table Catalent Pharmaceutical CDMO Services Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Siegfried Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Siegfried Product Profiles, Application and Specification

    • Table Siegfried Pharmaceutical CDMO Services Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Boehringer Ingelheim Product Profiles, Application and Specification

    • Table Boehringer Ingelheim Pharmaceutical CDMO Services Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.